Overview
Shu Hashimoto practices in Osaka, Japan. Hashimoto is rated as an Advanced expert by MediFind in the treatment of Eosinophilic Asthma. Their top areas of expertise are Asthma, Chronic Obstructive Pulmonary Disease (COPD), Eosinophilic Asthma, and Stridor.
Their clinical research consists of co-authoring 153 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Eosinophilic Asthma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AsthmaHashimoto isElite. Learn about Asthma.
- Distinguished
- Chronic Obstructive Pulmonary Disease (COPD)
- Advanced
- Eosinophilic AsthmaHashimoto isAdvanced. Learn about Eosinophilic Asthma.
- StridorHashimoto isAdvanced. Learn about Stridor.
- Experienced
- Acute Interstitial PneumoniaHashimoto isExperienced. Learn about Acute Interstitial Pneumonia.
- COVID-19Hashimoto isExperienced. Learn about COVID-19.
- Idiopathic Pulmonary FibrosisHashimoto isExperienced. Learn about Idiopathic Pulmonary Fibrosis.
- InfertilityHashimoto isExperienced. Learn about Infertility.
- Interstitial Lung DiseaseHashimoto isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaHashimoto isExperienced. Learn about Lung Adenocarcinoma.